Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 13, 2016 9:30 AM - Nov 15, 2016 5:30 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

13th DIA Japan Annual Meeting 2016

[V1-S4] What Roles should MA Division be in Charge of? - To Be the Bridge between Development and Academia as Well as Clinical Practice

Session Chair(s)

Kazuya  Iwamoto, MD, PhD, FACP

Kazuya Iwamoto, MD, PhD, FACP

Chairperson, The Japanese Association of Pharmaceutical Medicine (JAPhMed)

Senior Medical Director, Covance Inc., Japan

Recently, more and more pharmaceutical companies have been establishing Medical Affairs (MA) departments in Japan. MA plays important roles in optimizing value of products from medical/scientific perspective and in bridging between Development and Academia as well as Clinical Practice, having various responsibilities including Medical Information/Communication, engaging with Key Opinion Leaders, dealing with Investigator Sponsored Studies and reviewing promotional materials. Medical Science Liaison (MSL) plays a critical role in bridging between them and is being increasingly recognized by medical personnel and the pharmaceutical industry. This session will feature expert lectures on the roles/responsibilities required for MA and the current MA activities, followed by discussions on what roles MA should be in charge of in Japan.

Speaker(s)

Kazuya  Iwamoto, MD, PhD, FACP

The Core Role of MA

Kazuya Iwamoto, MD, PhD, FACP

Senior Medical Director, Covance Inc., Japan

Chairperson, The Japanese Association of Pharmaceutical Medicine (JAPhMed)

Yasushi  Matsuo

MSL Certification Accreditation

Yasushi Matsuo

AstraZeneca K.K., Japan

Vice President of Medical

Antonio  Martin, MD, PhD, MSc

What Pharmaceutical Companies Expect of, and How They Support Investigator Initiated Trials (IIT)

Antonio Martin, MD, PhD, MSc

Novartis Pharma K.K., Japan

Corporate Officer, Head Medical Division

Makoto  Shiragami, PhD

Issues with Provision of Prescription Drug Information

Makoto Shiragami, PhD

Teikyo Heisei University, Japan

Professor, Faculty of Pharmaceutical Sciences

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.